Medical Training AILongevity Supplement Evidence Review
You'll be able to critically evaluate common longevity supplements and NAD+ precursor strategies against the available evidence when patients ask about them.
What this track covers
This track covers the evidence base behind widely used longevity supplements, including NAD+ precursors, resveratrol, and metformin repurposing, with attention to how study quality and study population affect what conclusions can be drawn. It also addresses practical considerations clinicians face when patients bring in these agents, such as sourcing, quality variability, and how to frame conversations about uncertain evidence.
What you will practice
- Distinguish mechanistic and animal-model data from human clinical trial evidence for a given compound
- Identify gaps between marketed claims and what published trials actually measured
- Recognize which patient populations and comorbidities warrant more caution before discussing supplementation
- Evaluate product quality and sourcing red flags a patient might bring up
- Structure a patient conversation that presents evidence strength without overstating certainty
Simulator scenario
A patient on multiple longevity supplements presents for a routine visit and asks the clinician to review their current stack for interactions and evidence quality.
Board question topics
- Evidence hierarchy for anti-aging supplement claims
- Known interactions and contraindications for common longevity compounds
- Interpreting biomarker changes reported in supplement studies
- Recognizing marketing claims not supported by cited research
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free